Can amlodipine cause hair loss? This is a question many patients prescribed this common calcium channel blocker ask when they notice increased shedding or thinning. Amlodipine is widely used across the UK for hypertension and angina, and whilst it is generally well tolerated, hair loss — known medically as alopecia — is listed as a very rare side effect in its UK Summary of Product Characteristics. Understanding what the evidence actually shows, what else might be responsible, and when to seek medical advice is essential before making any changes to your blood pressure treatment.

Is Hair Loss a Recognised Side Effect of Amlodipine?

Hair loss is listed as a very rare side effect of amlodipine in its UK SmPC, occurring in fewer than 1 in 10,000 patients, though the vast majority of people taking amlodipine will not experience any change in hair growth.

Experiencing these side effects? Our pharmacists can help you navigate them →

Amlodipine is a calcium channel blocker widely prescribed in the UK for hypertension (high blood pressure) and angina. It works by relaxing the smooth muscle in blood vessel walls, reducing peripheral vascular resistance and lowering blood pressure. It is generally well tolerated, and the most commonly reported side effects include peripheral oedema (ankle swelling), flushing, headache, and dizziness.

Hair loss — medically termed alopecia — is listed as a very rare side effect of amlodipine in its UK Summary of Product Characteristics (SmPC), as approved by the MHRA and available on the Electronic Medicines Compendium (medicines.org.uk). 'Very rare' in pharmacovigilance terminology means it occurs in fewer than 1 in 10,000 patients. This classification is based on spontaneous post-marketing reports rather than controlled clinical trial data, which means a definitive causal relationship is difficult to establish with certainty. The NHS medicines information page for amlodipine similarly lists hair loss among very rare side effects.

It is important to note that while hair loss appears in the official side effect profile, it is not among the commonly expected adverse effects of amlodipine. The great majority of patients taking this medication will never experience any change in hair density or growth. If you have noticed hair thinning or shedding since starting amlodipine, it is worth discussing this with your GP or pharmacist — but it is equally important to consider other potential causes before attributing it solely to the medication.

What the Evidence Says About Amlodipine and Hair Loss

Evidence linking amlodipine to hair loss is limited to case reports and spontaneous adverse event data; no large randomised trials confirm causality, and a definitive causal link has not been established.

Not sure if this is normal? Chat with one of our pharmacists →

The evidence linking amlodipine directly to hair loss is limited and largely based on case reports and spontaneous adverse event reporting through systems such as the MHRA's Yellow Card scheme. There are no large-scale, randomised controlled trials that have identified alopecia as a significant or frequent outcome in patients taking amlodipine. This makes it challenging to draw firm conclusions about causality.

Some published case reports have described patients experiencing diffuse hair thinning or telogen effluvium — a condition where hair prematurely enters the resting (telogen) phase of the growth cycle — in temporal association with starting amlodipine. In several of these cases, hair loss reportedly improved after the medication was discontinued or switched. However, individual case reports represent the lowest level of clinical evidence, and confounding factors (such as concurrent illness, stress, or other medications) are difficult to rule out.

From a pharmacological standpoint, it has been hypothesised — though not proven — that calcium channel blockers may interfere with calcium-dependent processes involved in hair follicle cycling, given the role of calcium ions in regulating keratinocyte proliferation and differentiation within the follicle. This remains a speculative, hypothesis-level explanation and should not be taken as an established mechanism. There is no officially confirmed causal link between amlodipine and clinically significant alopecia, but the possibility cannot be entirely excluded on the basis of current post-marketing evidence.

Other Medications and Conditions That Can Cause Hair Loss

Thyroid disorders, iron deficiency anaemia, beta-blockers, anticoagulants, and androgenetic alopecia are among the more common causes of hair loss that should be excluded before attributing it to amlodipine.

Before attributing hair loss to amlodipine, it is essential to consider the wide range of other medications and underlying health conditions that are more commonly associated with alopecia. Many patients with hypertension are also taking multiple medicines, any of which could be contributing.

Medications in which hair loss has been reported include:

• Beta-blockers (e.g., bisoprolol, propranolol) — used for blood pressure, heart failure, and other cardiac conditions

• ACE inhibitors (e.g., lisinopril, ramipril) — though this is uncommon

• Anticoagulants such as warfarin and heparin — particularly with prolonged use

• Mood stabilisers such as lithium and sodium valproate — well-recognised causes

• Retinoids (e.g., acitretin, isotretinoin)

• Antithyroid drugs (e.g., carbimazole)

• Hormonal contraceptives

• Lipid-lowering agents, including some statins, in a small number of individuals

It is important to note that for most of these drug classes, hair loss is an uncommon or rare reported effect rather than a common one. The frequency and strength of evidence varies considerably between agents.

Beyond medications, several medical conditions can cause or worsen hair loss, including:

• Thyroid disorders (both hypothyroidism and hyperthyroidism) — a common and treatable cause

• Iron deficiency anaemia

• Alopecia areata — an autoimmune condition

• Androgenetic alopecia — the most common form of hair loss in both men and women

• Telogen effluvium triggered by physical or emotional stress, illness, or significant weight loss

Given that hypertension is often associated with other metabolic and cardiovascular conditions, it is important not to assume that amlodipine is the cause without a thorough clinical assessment. In line with NICE CKS guidance on alopecia, a GP can arrange appropriate blood tests — including thyroid function, full blood count, and ferritin (iron stores) — to investigate underlying causes before any changes to medication are considered.

When to Speak to Your GP or Pharmacist

Speak to your GP if hair loss is significant, rapid, or distressing, or if it began shortly after starting a new medication — but do not stop amlodipine without medical advice.

If you have noticed increased hair shedding, thinning, or patchy hair loss since starting amlodipine or any other new medication, it is advisable to raise this with your GP or pharmacist. You should not stop taking amlodipine without medical advice, as doing so could lead to a sudden rise in blood pressure, which carries its own significant health risks.

Consider contacting your GP if:

• Hair loss is significant, rapid, or causing distress

• You have noticed other new symptoms alongside hair loss — for example, fatigue, weight changes, or cold intolerance (which may suggest a thyroid problem), or nail changes and eyebrow or eyelash loss

• Hair loss began within weeks to months of starting a new medication

• You have a personal or family history of autoimmune conditions

• You notice scalp pain, burning, redness, scaling, pustules, or any signs of scarring — these may indicate a more serious condition requiring prompt assessment

• A child develops patchy hair loss with scaling or broken hairs, which may suggest tinea capitis (a fungal scalp infection)

Your GP may recommend blood tests to check thyroid function, full blood count, ferritin, and other relevant markers, in line with NICE CKS guidance on alopecia assessment. They will also review your full medication list to identify any more likely culprits. If a drug-related cause is suspected, they can discuss whether a trial period off the medication — or a switch to an alternative — is clinically appropriate and safe. Where the diagnosis is uncertain, or if scarring alopecia is suspected, your GP may refer you to NHS dermatology for specialist assessment.

You can also report suspected side effects directly to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk). This helps build the national evidence base for drug safety monitoring and is open to both patients and healthcare professionals.

Alternatives to Amlodipine if Side Effects Are a Concern

If amlodipine is suspected to be causing hair loss, NICE NG136-compliant alternatives include ACE inhibitors, ARBs, or thiazide-like diuretics, chosen according to your individual clinical profile under medical supervision.

If your GP agrees that amlodipine may be contributing to hair loss, there are several alternative antihypertensive medications that can be considered, depending on your individual clinical profile, comorbidities, and NICE guidance.

NICE guideline NG136 (Hypertension in adults: diagnosis and management) recommends a stepwise approach. Key points relevant to switching from amlodipine include:

• ACE inhibitors (e.g., ramipril, lisinopril) — preferred first-line options for people under 55 who are not of Black African or Caribbean family origin, and particularly suitable for those with diabetes or chronic kidney disease

• Angiotensin receptor blockers (ARBs) (e.g., losartan, candesartan) — suitable alternatives for those who develop a cough with ACE inhibitors

• Thiazide-like diuretics (e.g., indapamide) — recommended by NG136 as an alternative when a calcium channel blocker is not tolerated or is unsuitable

• Beta-blockers (e.g., bisoprolol) — not recommended as routine first-line treatment for uncomplicated hypertension, but may be appropriate for specific comorbid indications such as heart failure, angina, or at Step 4 of the treatment pathway; it is worth noting that beta-blockers are themselves associated with reported hair loss in some individuals

It is also worth noting that other dihydropyridine calcium channel blockers exist (e.g., felodipine, lercanidipine); however, if hair loss is suspected to be a class effect, switching within the same drug class may not resolve the problem.

It is important to understand that switching medication does not guarantee resolution of hair loss, particularly if another cause is responsible. Any change in antihypertensive therapy should be made gradually and under medical supervision, with blood pressure monitored closely during the transition. Self-discontinuing blood pressure medication is never advisable and can pose serious cardiovascular risks.

Managing Hair Loss While Taking Blood Pressure Medication

Gentle hair care, a nutrient-rich diet, and topical minoxidil (licensed for androgenetic alopecia) may help manage hair thinning; persistent or distressing hair loss warrants GP referral to NHS dermatology.

If investigations reveal no underlying medical cause and your GP advises continuing amlodipine — perhaps because it is the most effective option for your blood pressure control — there are practical steps you can take to support hair health and manage any thinning.

General hair and scalp care advice:

• Avoid excessive heat styling, tight hairstyles, or harsh chemical treatments that can worsen hair fragility

• Use gentle, sulphate-free shampoos and avoid over-washing

• Ensure a balanced diet rich in protein, iron, zinc, and vitamins to address any nutritional deficiencies that may compound hair changes

• If you are considering nutritional supplements, seek advice from your GP or pharmacist first; in particular, high-dose biotin (vitamin B7) supplements should be avoided unless clinically indicated, as the MHRA has issued safety advice warning that high biotin levels can interfere with a range of laboratory blood tests, potentially leading to inaccurate results

For some patients, topical minoxidil (available over the counter in the UK, e.g., Regaine) may be appropriate. It is licensed for androgenetic alopecia (pattern hair loss); use for telogen effluvium or other causes is off-label and should be discussed with a clinician before starting. Important considerations include:

• It is not suitable during pregnancy or breastfeeding

• An initial increase in shedding may occur in the first few weeks of use, which is usually temporary

• Local scalp irritation is a possible side effect

• Continued use is required to maintain any benefit; hair loss typically returns if treatment is stopped

If hair loss is persistent or distressing, ask your GP about referral to NHS dermatology for specialist assessment and management. You may also encounter private 'trichologists', but it is important to be aware that this title is not a regulated medical profession in the UK; NHS dermatology or a consultant dermatologist with a specialist interest in hair disorders is the appropriate clinical route.

It is also worth acknowledging the psychological impact of hair loss, which can significantly affect self-esteem and quality of life. If you are finding hair loss distressing, your GP can refer you to appropriate support services. Organisations such as Alopecia UK offer peer support and information for those affected.

Ultimately, the decision to continue, adjust, or change blood pressure medication should always be made collaboratively with your healthcare team, balancing any potential side effects against the well-established cardiovascular benefits of effective blood pressure control.

Frequently Asked Questions